Viracta Therapeutics
Patents, Design & Utilities
Last updated:
List of all Viracta Therapeutics patents 7 in total
Status | Patent |
---|---|
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS Filling date: 5 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: PHARMACEUTICAL FORMULATIONS, PROCESSES FOR PREPARATION, AND METHODS OF USE Filling date: 5 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Methods of treating virally associated cancers with histone deacetylase inhibitors Filling date: 5 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Methods and compositions for treating viral or virally-induced conditions Filling date: 5 Sep 2025 Issue date: 8 Dec 2020 |
Application | Utility: METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS Filling date: 5 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: EPIGENETIC MODIFIERS FOR USE IN CELLULAR IMMUNOTHERAPY Filling date: 5 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES Filling date: 5 Sep 2025 Issue date: 26 Sep 2019 |
Showing 1 to 7 of 7 patents.